Biopharma boycotts White House meeting
Trump had invited the executives to meet to discuss international reference pricing scheme
Biopharmaceutical industry CEOs informed the White House Monday that they would not attend a meeting that had been scheduled for Tuesday with President Donald Trump.
As a result of the CEO boycott, the White House has canceled the meeting.
Trump announced his meeting with drug company CEOs Friday at a signing ceremony for